UPDATE: AFT narrows net loss, turns cash flow positive

(Updates with further details in 2nd and 16th paragraphs, share price in last paragraph) By Jenny Ruth May 22 (BusinessDesk) - AFT Pharmaceuticals posted a narrower annual loss as interest and other finance costs swamped operating earnings and says it’s negotiating the refinancing of its debt at more favourable interest rates. Interest payments jumped more than 54 percent as borrowing increased and other increases in finance costs reflected foreign exchange movements. The marketer of over-the-counter medicines including Maxigesic pa...